Breast Pumps Market Insights on Market Challenges and New Trends

The rise in closed breast pumps market can be attributed to lower risk of contamination, and ease in cleaning process. Market players have successfully developed breast pumps with different functionalities such as pumping and bluetooth facilities, thus making it proficient for the lactating mothers.

Furthermore, closed breast pumps can be reused, without being harmful, thus increasing the convenience and safety offered by these pumps, which is anticipated to create huge opportunities for their growth

Breast Pumps Market is expected to garner $829 million by 2022, from $540 million in 2015, registering a CAGR of 6.6% from 2016 to 2022. Based on value, the battery-powered breast pump segment will account for more than two-thirds of the total market share in 2015 and will remain dominant during the forecast period. In terms of volume, the manual breast pump segment accounted for almost a quarter of the total market share in 2015

Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/5057

 The key players analyzed in the research include

·         Medela AG

·         Koninklijke Philips N.V. (Philips AVENT)

·         Ameda Inc.

·         Bailey Medical Engineering

·         Hygeia Health

·         Whittlestone Inc.

·         Linco Baby Merchandise Works Co. Ltd.

·         Pigeon Corporation

·         Energizer Holdings Inc.

·         Albert Manufacturing USA.

The surge in population of working women, increase in disposable income, and rise in awareness regarding importance of breastfeeding drive the growth in the global breast pumps market. Based on revenue, the closed system breast pumps segment contributed the major share of the market in 2015, and is expected to maintain its dominance during the forecast period along with registering the fastest CAGR of over 6% throughout the forecast period.

The personal use breast pumps contributed the highest share in terms of volume, registering a CAGR of nearly 6% during the forecast period. There is a rise in demand for personal use breast pump, owing to factors including effective pumping techniques, portability, and contamination-free feeding. On the other hand, the market for battery-powered breast pumps would grow at a considerable rate, owing to surge in preferences for efficient and portable pumping systems that presents an easy cleaning option.

Key findings of the report:

·         The closed system breast pumps segment would become the fastest growing segment in terms of value and volume, registering a CAGR of nearly 6.5% and 7% respectively, during the forecast period.

·         Asia-Pacific is expected to become the fastest growing segment, registering a CAGR of 9.7%, on the basis of value, from 2016 to 2022.

·         In 2015, North America contributed nearly three-fifths of the total share in the global breast pumps market based on value.

·         The hospital grade breast pumps would generate the highest revenue during the period, 2016-2022.

·         In 2015, the battery powered breast pumps segment became the leading segment and is expected to register the highest growth rate in global breast pump market at CAGR of 6.4% during the forecast period.

·         Mexico would become the fastest growing market from the North American region.

·         China and Japan would become the leading countries for breast pumps in the Asia-Pacific region.

Geographically, North America held the major market share in 2015, owing to the surge in adoption of breast pump techniques across the region. However, Asia-Pacific is estimated to grow at the fastest rate, owing to surge in medical needs and rise in awareness about breastfeeding. In terms of value, Europe contributed approximately one-fifth of the total share of the overall market in 2015, owing to a huge number of women utilizing breast pumps.

Antibiotics Market to Expand at a Steady Growth Rate in the Coming Years

Antibiotics Market generated $42.33 billion in 2017 and is expected to reach $50.37 billion by 2025, registering a CAGR of 2.1% from 2018 to 2025.

Increasing utilization of antibiotics in low and middle-income countries (LMICs) due to high incidence of severe infections, high capital allocation for R&D activities by biotech companies, and supportive norms and regulations drive the growth of the market. However, development of antibiotic resistance and rise in drug approval costs hinder the market growth. Conversely, discovery of advanced prospect molecules and innovative combination therapies for the treatment of antibiotic-resistant microbial infections would create opportunities for the market in future.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5072

Beta lactam and beta lactamase inhibitors segment to maintain its dominance by 2025 

The beta lactam and beta lactamase inhibitors segment contributed nearly two-thirds of the total market share in 2017 and is expected to maintain its dominance by 2025. This is due to rise in demand for its effectiveness in treating Gram-positive & Gram-negative bacteria as well as use in the treatment of broad-spectrum of infections. However, quinolones segment would register the fastest CAGR of 4.3% from 2018 to 2025, owing to their characteristics such as remarkable oral bioavailability, good tissue penetration, and high broad-spectrum bactericidal activity, especially in new generation quinolones. The report also analyzes macrolides and others.

Semisynthetic segment to lead throughout the forecast period 

The semisynthetic segment accounted for more than one-third of the total market share in 2017 and will continue to maintain its lead by 2025. This is due to the enhanced coverage and efficacy against a wide range of organisms as well as ease in administration and cost effectiveness as compared to other antibiotics. However, the synthetic segment would register the fastest CAGR of 2.7% from 2018 to 2025 due to high demand for synthetic membrane-targeted antibiotics, broad spectrum activity, rapid bactericidal activity, no cross-resistance with existing antibiotics, and low probability of developing resistance. The report also discusses antibiotics of natural origin.

Broad-spectrum antibiotics segment to be lucrative by 2025 

Broad-spectrum antibiotics segment contributed more than two-thirds of the total market share in 2017. This segment would dominate by 2025, registering the fastest CAGR of 2.4% from 2018 to 2025. This is attributed to the growing demand for broad-spectrum antibiotics to curb widespread antimicrobial resistance. The research also discusses narrow-spectrum antibiotics.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/5072

Intravenous segment to dominate in terms of revenue during the forecast period  

Intravenous route of administration segment accounted for nearly half of the total market share in 2017, owing to the rise in incidence of severe infections, which requires intravenous antibiotics for reaching the tissues faster and achieving higher concentrations as compared to oral antibiotics. This segment would maintain its lead position by 2025. However, the oral segment would grow at the highest CAGR of 2.5% from 2018 to 2025, owing to ease in self-administration, which results in high demand for oral drugs and reduction in hospital stay.

Asia-Pacific to register the highest revenue by 2025 

Asia-Pacific region contributed more than one-third of the total market share in 2017, owing to the burgeoning rate of antibiotics consumption, ease in availability of antibiotics, and increase in sales of antibiotics without prescription. This region would continue to dominate throughout the forecast period. However, LAMEA region would grow at the fastest CAGR of 3.5% from 2018 to 2025. This is due to easy of availability and relaxed legislations or restrictions on their usage in this region.

Leading market players 

The key market players analyzed in the report include Abbott Laboratories, F.Hoffmann-La Roche Ltd., Allergan Plc., Merck & Co. Inc., GlaxoSmithKline plc, Novartis International AG (Sandoz), Mylan N.V., Sanofi, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. They have implemented various strategies such as expansions, mergers & acquisitions, joint ventures, partnerships, collaborations, and others to achieve a strong position in the industry.

Smart Insulin Pens Market - Growing Trends and Business Opportunities

The benefits offered by smart insulin pens is the major factor driving the growth of the market. For instance, a patient experiences less injection pain while using smart insulin pen, which in turn propels the market growth.

Smart Insulin Pens Market was valued at $57 million in 2016, and is projected to reach $117 million by 2023, growing at a CAGR of 10.7% from 2017 to 2023. The first generation pens segment held more than three-fifths share of the total market in 2016.

Smart insulin pen is used to deliver insulin into diabetic patients. Increase in demand for self-injection devices, rise in prevalence of diabetes, and accuracy in dosage delivery of insulin are expected to drive the market growth. However, limited usage of smart insulin pens for patients requiring a mixture of two types of insulin restrict the market growth.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/3485

First generation pens are expected to dominate the market throughout the analysis period. However, the second generation pens segment is expected to register the highest CAGR of 12.3%.

Asia-Pacific is projected to register the highest CAGR of 12.0%, owing to rise in incidence of diabetes coupled with rising geriatric population. In addition, surge in awareness of benefits of smart insulin pens, such as it is beneficial for people with vision problems, offers a lucrative opportunity for the market growth.

The major companies profiled in the report are Eli Lilly and Company, Novo Nordisk, Companion Medical, DIAMESCO, and Emperra GmbH.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3485

Key Findings of the Smart Insulin Pens Market :

• The first generation pens is projected to grow at the CAGR of 9.7% during the forecast period.
• USB connected pens is projected to register the highest growth rate of 12.7% during the forecast period.
• Bluetooth-enabled pens segment accounted nearly two-thirds share of the global second generation smart insulin pens market in 2016.
• Home care settings is expected to grow at the highest CAGR of 10.9% during the forecast period.
• France and Germany collectively contributed for more than one-third share of the European smart insulin pens market in 2016.
• Japan was the major shareholder in 2016, accounting for more than one-third share of the Asia-Pacific smart insulin pens market.

Colorants Market - Growing Trends and Business Opportunities

Global colorant market is projected to reach $64 billion by 2023 from $41 billion in 2016, at a CAGR of 6.5%. Colors are added to products to enhance their appeal. Pigment and dyes are the most common colorants added to food items, clothes, paper, and beverages, in liquid, liquid gel, gel paste, and powder form. Dyes can be natural or synthetic. Natural dyes are available from plants, animals, and minerals.

Increased demand from end-use industry such as plastic, paints & coatings, automotive, and packaging drive the market. However, ban on trade of artificial colorants hampers the market growth. Oversupply of dyes, leading to its decreased prices also restraints the market. Technological advancement is seen as a major growth opportunity for colorants manufacturers.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/3812

Asia-Pacific and Europe collectively contributed about 5% share of the global market in 2016 owing to the increased consumption of colorant from packaging, textile, and paper & printing industry.

The key players profiled in the report include BASF SE, Sun Chemical Corporation, Clariant AG, Polyone Corporation, E. I. Du Pont De Nemours and Company, Lanxess, Huntsman Corporation, Dystar, DIC Corporation, and Cabot Corporation.

The other key players in the value chain (not profiled in this report) include Sudarshan Chemical Industries Limited, The DOW Chemical Company, The Chemours Company, Flint Group, and Archroma.

Ingredients or combination of ingredients used to offer the required appearance to any products, such as clothes, paper, and beverages are termed as colorants. The most widely used colorants are dyes and pigments. Dyes are water soluble and are available naturally or are processed synthetically. Natural dyes are obtained from flora, fauna, and minerals. These are used in packaging, building & construction, automotive, textiles, paper & printing, and others.

Rise in the plastic, paints & coatings, and cosmetics industry in the emerging economies such as, India, Brazil, UAE, Saudi Arabia, and Africa. Moreover, the increased consumer spending on packaged food boost the market growth. In addition, the ever-growing technological advancements and easy availability of dyes from plants and animals support the growth. However, the market growth for colorant is restricted by the ban on the usage of artificial colorants. Technological advancements offer food colorant manufacturers numerous growth opportunity.

In 2016, the packaging segment accounted for the highest share, and is expected to maintain its dominance during the forecast period, owing to the increased consumption of packaged food & beverages in almost all the regions.

Key Findings of the Colorants Market:

·         Asia-Pacific was the leading region in the global colorants market in 2016, followed by Europe

·         The pigment segment generated the highest revenue in 2016, and is projected to grow at a CAGR of 7.2% during the forecast period

·         The packaging segment dominated the global market accounting for approximately one-third share in 2016

·         The Asia-Pacific food colors market is anticipated to register the highest CAGR of 7.2%, followed by LAMEA

·         North America accounted for approximately one-fifth share in the global market, and is expected to grow at a CAGR of 5.9%.

Make an Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3812

Canine Specialty Drugs Market Statistics 2019: New Launches and Innovation to Boost Growth

Rise in adoption of canine, rise in canine health awareness, increase in R&D for canine specialty drugs with augment in canine population, introduction of cost-effective drugs, growth in prevalence of several canine diseases, and research in technological, and biomedical advances regarding the treatment of various canine diseases are the factors that primarily drive the growth of the Canine Specialty Drugs Market. Canine specialty drugs market is expected to be dominated by markets are North America, followed by Europe. Asia-Pacific is anticipated to exhibit the fastest growth rate. However, complex problems involved in the disease of canine restrains the growth of the canine specialty drugs market across the globe. 

Canine is a dog-like animal which is conventionally designated as canid. Canines include 36 living species of foxes, wolves, jackals, and other members of the dog family. Canine is long- legged animals with long muzzles, erect pointed ears and busy tails. In 36 species of canine, 12 genera found which are genus vulpes, genus canis, genus pseudalopex, genus urocyon, genus atelocynus, genus Cerdocyon, genus chrysocyon, genus cuon, genus Lycaon, genus nytereutes, genus otocyon, and genus speothos. Species of this genus are differentiated by their moderate to large size, their massive, well-developed skulls and dentition, long legs, and short ears and tails. Canine suffer from different type of diseases. Treatment of canine diseases can be done with different drug categories like nonsteroidal anti-inflammatory drugs, anti-infectives, parasiticides, vaccines, and hormonal drugs.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-toc-and-sample/5468

The canine specialty drugs market is segmented based on drug type, route of administration, and region. Based on drug type, the market is segmented into nonsteroidal anti-inflammatory drugs, anti-infective, parasiticides, vaccines, and hormonal drugs. Nonsteroidal anti-inflammatory drugs or NSAIDs help to reduce swelling, joint pain, and stiffness in canine. The nonsteroidal anti-inflammatory drugs include carprofen, deracoxib, firocoxib, and meloxicam. The anti-infective drugs are used for fungal infection and bacterial infection. For fungal infection, ketoconazole is used for variety of fungal infections in dose range 5 to 10 mg/kg PO q12-24h. For bacterial infection, doxycycline is commonly used to treat bacterial infection plethora in dose range from 3 to 5 mg/kg q12-24 hours. Under parasiticides drugs category, the drugs which are most commonly used are nitenpyram, epsiprantel, Spinosad, praziquantel, fipronil and methoprene, and ivermectin. Under vaccines category, there are two types of vaccines available such as core vaccines and non-core vaccines. Under hormonal drugs levothyroxine is most popular medication for dogs. Based on route of distribution, the market is divided into oral, parenteral, and topical. Based on region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the canine specialty market include Boehringer Ingelheim, Merck animal health, Zoetis animal health, Sanofi S.A. (MERIAL Limited), Elanco (Eli Lilly and Company), Novartis animal health, Virbac group, Vetoquinol S. A., Bayer Healthcare, and Ceva Sante Animale.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/5468

KEY BENEFITS FOR STAKEHOLDERS

• This report provides a detailed quantitative analysis of the current market trends and market forecast estimations from 2019 to 2026, which assists to identify the prevailing canine specialty drugs market opportunities. 
• An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.
• Region-wise and country-wise canine specialty drugs market conditions are comprehensively analyzed in this report.
• The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
• Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global canine specialty drugs market.  

Palliative care Market to Witness Heightened Revenue Growth During the Prediction Period

Increase in chronic life-threatening diseases, reimbursement from Medicaid and Medicare, surge in the aging population, favorable initiative taken by the government and non- profit organization, and rise in government funding in healthcare system are the factors that drive the growth of the Palliative Care Market. Palliative care centers are recognized as a medical subspecialty by the American board of medical specialties and in Canada, England, Australia, New Zealand and Ireland. European countries are also in the process of developing a certification of palliative care. Palliative centers are also being developed in nations such as India, Indonesia, Brazil, and China. The palliative services market is being established in these markets and is expected to be in great demand with rise in awareness. However, high cost of the treatment, less expansion of medical care facilities for old age group, and lack of awareness can hinder the growth of the palliative care market across the globe. 

Palliative care is a medical care approach for people with serious illness. The goal of palliative care is to improve the quality of life of both patient and the family through prevention and relief of suffering by early identification and treatment of different pain and other issues. Palliative care is provided by a team of physicians, nurses, physiotherapists, occupational therapists, pathologists, and other healthcare professionals. Palliative care is provided to patients suffering from diseases such as cancer, congestive heart failure (CHF), CNS disorders, chronic pulmonary obstructive disease (COPD) and providing symptomatic relief for nausea, vomiting, diarrhea, pain, anxiety, and loss of appetite. According to the National Hospice & Palliative Care Organization (NHPCO), in 2014, approximately 1.7 million patients received services from palliative care centers.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-toc-and-sample/5482

The palliative care market is segmented based on type, application, end user, and region. Based on type, the market is segmented into private residence care, hospice inpatient care, nursing home, residential facility center, and others. Based on application, the market is classified into cancer, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), kidney failure, Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS) and others. Based on end user, the market is divided into hospitals, home care settings, palliative care centers, and long-term care centers & rehabilitation centers. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the Palliative care market include Skilled Healthcare Group Incorporated, Vitas Healthcare Corporation, Sunrise Senior Living LLC, Kindred Healthcare Incorporated, Gentiva Health Services Incorporated, Home Instead Senior Care Incorporated, Amedisys Incorporated, Genesis HealthCare Corporation, GGNSC Holdings LLC. And Senior Care Centers of America.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/5482

KEY BENEFITS FOR STAKEHOLDERS

• This report provides a detailed quantitative analysis of the current market trends and market forecast estimations from 2019 to 2026, which assists to identify the prevailing palliative care market opportunities. 
• An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.
• Region-wise and country-wise palliative care market conditions are comprehensively analyzed in this report.
• The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
• Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global palliative care market.  

Oncology Nutrition Market Anticipated to Grow at an Impressive Rate during the Period

Development of elemental formulas and launch of new products for nutrition of oncology patients, rise in prevalence of cancer, increase in focus on enteral nutrition, surge in demand for nutritional food from the homecare sector are expected to drive the Oncology Nutrition Market in the coming years.

Moreover, rise in clinical research on nutritional interventions, and increase in awareness for nutrition of cancer patients are expected to boost the oncology nutrition market during the forecast period. However, tube feeding-related complications and restricted reimbursement associated with its use are the major restraints that can hamper the growth of the market. In addition, rapid product origination and improvement of elemental formulas in the field are expected to provide numerous opportunities for the oncology nutrition market in the coming years.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-toc-and-sample/5481

Some of the major players operating in the oncology nutrition market include FMC Corporation, Danone, Abbott Laboratories, Aceto, B. Braun Melsungen AG, Baxter International, BioSig Technologies, Fresenius Kabi AG, Global Health Products, Hansen Medical, Hormel Foods, Mead Johnson Nutrition Company, Meiji Holdings, Nestle S.A., and Victus.

Cancer involves uncontrollable growth of abnormal cells. These cells are called as tumor cells or malignant cells. The field of medication that deals with the avoidance, treatment, and analysis of cancer is known as oncology. Oncology nutrition is termed as nutrition and diet for a cancer patient either during treatment or after the treatment. Nutrition plays a significant role in several aspects of cancer development and is an important helpful therapy during cancer treatment.

Adequate nutrition provision can help cancer patients to maintain weight and slim body composition, offering improved recovery, and better quality of life. Right nutrition for a patient suffering from cancer delivers strength to fight with the illness. The correct food helps the patient endure the distressing effects of cancer and its treatment. Good nutrition also provides more energy and improves the quality of life by dealing with side effects of treatment and helps in speeding the recovery of the patient. Furthermore, it also helps in healing wounds after chemotherapy, radiotherapy, surgery, or other treatment. 

The oncology nutrition market is segmented based on type of cancer, and region. Based on type of cancer, the market is categorized into head & neck cancer, stomach and gastrointestinal cancers, esophageal cancer, pancreatic cancer, liver cancer, blood cancer, breast cancer, and other cancers. The neck and head segment accounted for an important share of the oncology nutrition market.  Neck and head cancer patients suffer from chronic problems associated to oral nutritional consumption through enteral route for nutrition support. The use of tube nurturing formulas has experienced growth with an increase in the number of cancer cases.

The neck and head cancer reports for around 4% of all cancers in the U.S. American Society of Clinical Oncology (ASCO), in 2017, reported that 64,690 people (17,040 women and 47,650 men) developed neck and head cancer in 2017. Based on region, the oncology nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/5481

KEY BENEFITS FOR STAKEHOLDERS

·         This report provides a detailed quantitative analysis of the current market trends and market forecast estimations from 2019 to 2026, which helps identify the prevailing oncology nutrition market opportunities. 

·         An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

·         A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.

·         Region-wise and country-wise oncology nutrition market conditions are comprehensively analyzed in this report.

·         The projections in this report are made by analyzing the current market trends and future market potential from 2019 to 2026 in terms of value.

·         analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.An extensive

Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global oncology nutrition market.